Energy -
Oil & Gas Midstream - NYSE - US
$ 57.91
0.836 %
$ 1.97 B
Market Cap
24.03
P/E
1. INTRINSIC VALUE
Balance Sheet
Global Partners LP
| Current Assets | 1.1 B |
| Cash & Short-Term Investments | 19.6 M |
| Receivables | 560 M |
| Other Current Assets | 518 M |
| Non-Current Assets | 2.43 B |
| Long-Term Investments | 94.4 M |
| PP&E | 1.77 B |
| Other Non-Current Assets | 574 M |
| Current Liabilities | 983 M |
| Accounts Payable | 649 M |
| Short-Term Debt | 76.7 M |
| Other Current Liabilities | 257 M |
| Non-Current Liabilities | 1.66 B |
| Long-Term Debt | 1.46 B |
| Other Non-Current Liabilities | 201 M |
EFFICIENCY
Earnings Waterfall
Global Partners LP
| Revenue | 16.5 B |
| Cost Of Revenue | 16 B |
| Gross Profit | 514 M |
| Operating Expenses | 266 M |
| Operating Income | 244 M |
| Other Expenses | 101 M |
| Net Income | 143 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Global Partners LP
| Net Income | 143 M |
| Depreciation & Amortization | 110 M |
| Capital Expenditures | -402 M |
| Stock-Based Compensation | 10.6 M |
| Change in Working Capital | 233 M |
| Others | -43.2 M |
| Free Cash Flow | 110 M |
Wall Street Analysts Price Targets
Global Partners LP
GLP has no price targets from Wall Street.
4. DIVIDEND
ANALYSIS
1.89%
DIVIDEND YIELD
0.74 USD
DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership
Global Partners LP
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
1.49 M USD 1
0-3 MONTHS
3.86 M USD 1
3-6 MONTHS
3.75 M USD 1
6-9 MONTHS
5.29 M USD 1
9-12 MONTHS
| Date | Value | Insider | Amount | Avg Price |
|---|---|---|---|---|
|
2 months ago
Dec 24, 2024
|
Bought
148 K USD
|
Global GP LLC
other: General Partner
|
+ 3000
|
49.39 USD |
|
2 months ago
Dec 23, 2024
|
Bought
142 K USD
|
Global GP LLC
other: General Partner
|
+ 3000
|
47.35 USD |
|
2 months ago
Dec 20, 2024
|
Bought
146 K USD
|
Global GP LLC
other: General Partner
|
+ 3000
|
48.67 USD |
|
2 months ago
Dec 19, 2024
|
Bought
143 K USD
|
Global GP LLC
other: General Partner
|
+ 3000
|
47.76 USD |
|
2 months ago
Dec 18, 2024
|
Bought
147 K USD
|
Global GP LLC
other: General Partner
|
+ 3000
|
48.84 USD |
|
2 months ago
Dec 17, 2024
|
Bought
99.4 K USD
|
Global GP LLC
other: General Partner
|
+ 2000
|
49.7 USD |
|
2 months ago
Dec 16, 2024
|
Bought
104 K USD
|
Global GP LLC
other: General Partner
|
+ 2000
|
52.17 USD |
|
2 months ago
Dec 12, 2024
|
Bought
275 K USD
|
Global GP LLC
other: General Partner
|
+ 5000
|
55.05 USD |
|
2 months ago
Dec 09, 2024
|
Bought
281 K USD
|
Global GP LLC
other: General Partner
|
+ 5000
|
56.17 USD |
|
3 months ago
Nov 25, 2024
|
Bought
263 K USD
|
Global GP LLC
other: General Partner
|
+ 5000
|
52.66 USD |
|
3 months ago
Nov 20, 2024
|
Bought
254 K USD
|
Global GP LLC
other: General Partner
|
+ 5000
|
50.9 USD |
|
3 months ago
Nov 19, 2024
|
Bought
259 K USD
|
Global GP LLC
other: General Partner
|
+ 5000
|
51.81 USD |
|
3 months ago
Nov 18, 2024
|
Bought
254 K USD
|
Global GP LLC
other: General Partner
|
+ 5000
|
50.76 USD |
|
3 months ago
Nov 15, 2024
|
Bought
248 K USD
|
Global GP LLC
other: General Partner
|
+ 5000
|
49.51 USD |
|
3 months ago
Nov 14, 2024
|
Bought
246 K USD
|
Global GP LLC
other: General Partner
|
+ 5000
|
49.25 USD |
|
5 months ago
Sep 20, 2024
|
Bought
99.5 K USD
|
Global GP LLC
other: General Partner
|
+ 2226
|
44.71 USD |
|
5 months ago
Sep 18, 2024
|
Bought
220 K USD
|
Global GP LLC
other: General Partner
|
+ 5000
|
44.02 USD |
|
5 months ago
Sep 17, 2024
|
Bought
91.6 K USD
|
Global GP LLC
other: General Partner
|
+ 2100
|
43.6 USD |
|
5 months ago
Sep 16, 2024
|
Bought
215 K USD
|
Global GP LLC
other: General Partner
|
+ 5000
|
43.07 USD |
|
5 months ago
Sep 13, 2024
|
Bought
214 K USD
|
Global GP LLC
other: General Partner
|
+ 5000
|
42.84 USD |
|
5 months ago
Sep 11, 2024
|
Bought
219 K USD
|
Global GP LLC
other: General Partner
|
+ 5000
|
43.85 USD |
|
5 months ago
Sep 11, 2024
|
Bought
219 K USD
|
Global GP LLC
other: General Partner
|
+ 5000
|
43.85 USD |
|
5 months ago
Sep 10, 2024
|
Bought
207 K USD
|
Global GP LLC
other: General Partner
|
+ 4800
|
43.17 USD |
|
5 months ago
Sep 05, 2024
|
Bought
212 K USD
|
Global GP LLC
other: General Partner
|
+ 5000
|
42.4 USD |
|
5 months ago
Sep 04, 2024
|
Bought
210 K USD
|
Global GP LLC
other: General Partner
|
+ 5000
|
42.06 USD |
|
5 months ago
Sep 03, 2024
|
Bought
422 K USD
|
Global GP LLC
other: General Partner
|
+ 10000
|
42.21 USD |
|
6 months ago
Aug 30, 2024
|
Bought
227 K USD
|
Global GP LLC
other: General Partner
|
+ 5000
|
45.34 USD |
|
6 months ago
Aug 29, 2024
|
Bought
338 K USD
|
Global GP LLC
other: General Partner
|
+ 7500
|
45.08 USD |
|
6 months ago
Aug 28, 2024
|
Bought
215 K USD
|
Global GP LLC
other: General Partner
|
+ 5000
|
42.98 USD |
|
6 months ago
Aug 27, 2024
|
Bought
213 K USD
|
Global GP LLC
other: General Partner
|
+ 5000
|
42.67 USD |
|
6 months ago
Aug 19, 2024
|
Bought
101 K USD
|
Global GP LLC
other: General Partner
|
+ 2400
|
41.88 USD |
|
6 months ago
Aug 15, 2024
|
Bought
52.6 K USD
|
Global GP LLC
other: General Partner
|
+ 1300
|
40.49 USD |
|
8 months ago
Jun 20, 2024
|
Bought
457 K USD
|
Global GP LLC
other: General Partner
|
+ 10000
|
45.68 USD |
|
8 months ago
Jun 18, 2024
|
Bought
229 K USD
|
Global GP LLC
other: General Partner
|
+ 5000
|
45.71 USD |
|
8 months ago
Jun 17, 2024
|
Bought
474 K USD
|
Global GP LLC
other: General Partner
|
+ 10000
|
47.37 USD |
|
8 months ago
Jun 10, 2024
|
Bought
502 K USD
|
Global GP LLC
other: General Partner
|
+ 10000
|
50.23 USD |
|
9 months ago
May 31, 2024
|
Bought
476 K USD
|
Global GP LLC
other: General Partner
|
+ 10000
|
47.61 USD |
|
9 months ago
May 30, 2024
|
Bought
467 K USD
|
Global GP LLC
other: General Partner
|
+ 10000
|
46.69 USD |
|
9 months ago
May 29, 2024
|
Bought
461 K USD
|
Global GP LLC
other: General Partner
|
+ 10000
|
46.14 USD |
|
9 months ago
May 28, 2024
|
Bought
446 K USD
|
Global GP LLC
other: General Partner
|
+ 10000
|
44.63 USD |
|
9 months ago
May 24, 2024
|
Bought
449 K USD
|
Global GP LLC
other: General Partner
|
+ 10000
|
44.92 USD |
|
9 months ago
May 23, 2024
|
Bought
446 K USD
|
Global GP LLC
other: General Partner
|
+ 10000
|
44.62 USD |
|
9 months ago
May 22, 2024
|
Bought
435 K USD
|
Global GP LLC
other: General Partner
|
+ 10000
|
43.49 USD |
|
9 months ago
May 21, 2024
|
Bought
454 K USD
|
Global GP LLC
other: General Partner
|
+ 10000
|
45.37 USD |
|
9 months ago
May 20, 2024
|
Bought
450 K USD
|
Global GP LLC
other: General Partner
|
+ 10000
|
44.96 USD |
|
9 months ago
May 17, 2024
|
Bought
440 K USD
|
Global GP LLC
other: General Partner
|
+ 10000
|
44.05 USD |
|
9 months ago
May 16, 2024
|
Bought
436 K USD
|
Global GP LLC
other: General Partner
|
+ 10000
|
43.56 USD |
|
9 months ago
May 15, 2024
|
Bought
433 K USD
|
Global GP LLC
other: General Partner
|
+ 10000
|
43.29 USD |
|
9 months ago
May 14, 2024
|
Bought
414 K USD
|
Global GP LLC
other: General Partner
|
+ 10000
|
41.43 USD |
|
9 months ago
May 13, 2024
|
Bought
427 K USD
|
Global GP LLC
other: General Partner
|
+ 10000
|
42.66 USD |
|
1 year ago
Dec 08, 2023
|
Bought
302 K USD
|
Global GP LLC
|
+ 8000
|
37.78 USD |
|
1 year ago
Nov 28, 2023
|
Bought
350 K USD
|
Global GP LLC
|
+ 10000
|
34.99 USD |
|
1 year ago
Nov 27, 2023
|
Bought
341 K USD
|
Global GP LLC
|
+ 10000
|
34.1 USD |
|
1 year ago
Nov 21, 2023
|
Bought
343 K USD
|
Global GP LLC
|
+ 10000
|
34.26 USD |
|
1 year ago
Nov 20, 2023
|
Bought
341 K USD
|
Global GP LLC
|
+ 10000
|
34.11 USD |
|
1 year ago
Nov 16, 2023
|
Bought
333 K USD
|
Global GP LLC
|
+ 10000
|
33.34 USD |
|
1 year ago
Nov 15, 2023
|
Bought
505 K USD
|
Global GP LLC
|
+ 15000
|
33.64 USD |
|
1 year ago
Nov 14, 2023
|
Bought
329 K USD
|
Global GP LLC
|
+ 10000
|
32.88 USD |
|
1 year ago
Sep 25, 2023
|
Bought
13.5 K USD
|
Global GP LLC
|
+ 415
|
32.49 USD |
|
1 year ago
Sep 21, 2023
|
Bought
330 K USD
|
Global GP LLC
|
+ 10000
|
33 USD |
|
1 year ago
Sep 19, 2023
|
Bought
331 K USD
|
Global GP LLC
|
+ 10000
|
33.12 USD |
|
1 year ago
Aug 09, 2023
|
Bought
24.8 K USD
|
Kelly Clare McGrory
Director
|
+ 800
|
30.99 USD |
|
1 year ago
May 17, 2023
|
Sell 12.4 K
USD
|
Pereira Jaime
Director
|
- 400
|
31 USD |
|
2 years ago
Nov 25, 2022
|
Bought
67.5 K USD
|
Global GP LLC
Director
|
+ 2100
|
32.13 USD |
|
2 years ago
Nov 23, 2022
|
Bought
63 K USD
|
Global GP LLC
Director
|
+ 2000
|
31.5 USD |
|
2 years ago
Nov 21, 2022
|
Bought
90.6 K USD
|
Global GP LLC
Director
|
+ 3000
|
30.2 USD |
|
2 years ago
Nov 18, 2022
|
Bought
78.3 K USD
|
Global GP LLC
Director
|
+ 2584
|
30.3 USD |
|
2 years ago
Nov 16, 2022
|
Bought
31.2 K USD
|
Global GP LLC
Director
|
+ 1000
|
31.2 USD |
|
2 years ago
Sep 16, 2022
|
Bought
28.4 K USD
|
Pereira Jaime
Director
|
+ 1000
|
28.45 USD |
|
2 years ago
Aug 25, 2022
|
Bought
27.8 K USD
|
Pereira Jaime
Director
|
+ 1000
|
27.85 USD |
|
2 years ago
May 19, 2022
|
Sell 60.6 K
USD
|
Langhorn Jeremy
Chief Human Resources Officer
|
- 2191
|
27.67 USD |
|
2 years ago
Jun 23, 2022
|
Bought
115 K USD
|
Global GP LLC
director:
|
+ 5000
|
23.01 USD |
|
2 years ago
Jun 23, 2022
|
Bought
120 K USD
|
Global GP LLC
other: General Partner
|
+ 5433
|
22.05 USD |
|
2 years ago
Jun 22, 2022
|
Bought
173 K USD
|
Global GP LLC
other: General Partner
|
+ 7500
|
23.01 USD |
|
2 years ago
Jun 21, 2022
|
Bought
65.3 K USD
|
Global GP LLC
director:
|
+ 2900
|
22.51 USD |
|
2 years ago
Jun 17, 2022
|
Bought
134 K USD
|
Global GP LLC
other: General Partner
|
+ 6545
|
20.46 USD |
|
2 years ago
Jun 16, 2022
|
Bought
107 K USD
|
Global GP LLC
other: General Partner
|
+ 5000
|
21.37 USD |
|
2 years ago
Jun 15, 2022
|
Bought
241 K USD
|
Global GP LLC
director:
|
+ 10000
|
24.09 USD |
|
2 years ago
May 31, 2022
|
Bought
541 K USD
|
Global GP LLC
director:
|
+ 18119
|
29.85 USD |
|
2 years ago
May 31, 2022
|
Bought
445 K USD
|
Global GP LLC
other: General Partner
|
+ 15075
|
29.55 USD |
|
2 years ago
May 24, 2022
|
Bought
424 K USD
|
Global GP LLC
director:
|
+ 14786
|
28.66 USD |
|
2 years ago
May 24, 2022
|
Bought
195 K USD
|
Global GP LLC
other: General Partner
|
+ 6940
|
28.08 USD |
|
3 years ago
Jun 18, 2021
|
Bought
239 K USD
|
Global GP LLC
|
+ 9120
|
26.18 USD |
|
3 years ago
Jun 17, 2021
|
Bought
544 K USD
|
Global GP LLC
|
+ 20653
|
26.35 USD |
|
3 years ago
Jun 16, 2021
|
Bought
436 K USD
|
Global GP LLC
|
+ 16224
|
26.9 USD |
|
3 years ago
Jun 15, 2021
|
Bought
143 K USD
|
Global GP LLC
|
+ 5412
|
26.4 USD |
|
3 years ago
Jun 14, 2021
|
Bought
666 K USD
|
Global GP LLC
|
+ 25000
|
26.62 USD |
|
3 years ago
Jun 09, 2021
|
Bought
570 K USD
|
Global GP LLC
|
+ 20974
|
27.18 USD |
|
3 years ago
Jun 07, 2021
|
Bought
630 K USD
|
Global GP LLC
|
+ 23551
|
26.74 USD |
|
3 years ago
Jun 04, 2021
|
Bought
535 K USD
|
Global GP LLC
|
+ 20404
|
26.2 USD |
|
3 years ago
May 12, 2021
|
Sell 70.7 K
USD
|
McCool Robert J
Director
|
- 3000
|
23.57 USD |
|
4 years ago
Jun 29, 2020
|
Bought
21.5 K USD
|
Global GP LLC
|
+ 2193
|
9.81 USD |
|
4 years ago
Jun 26, 2020
|
Bought
267 K USD
|
Global GP LLC
|
+ 27807
|
9.6 USD |
|
4 years ago
Mar 24, 2020
|
Bought
21.6 K USD
|
Slifka Richard
director, 10 percent owner:
|
+ 1800
|
11.99 USD |
|
4 years ago
Mar 24, 2020
|
Bought
20.4 K USD
|
Slifka Andrew P.
Executive Vice President
|
+ 1700
|
12 USD |
|
4 years ago
Mar 23, 2020
|
Bought
14.6 K USD
|
Slifka Andrew P.
Executive Vice President
|
+ 1065
|
13.73 USD |
|
4 years ago
Mar 23, 2020
|
Bought
2.29 K USD
|
Slifka Andrew P.
Executive Vice President
|
+ 200
|
11.46 USD |
|
4 years ago
Mar 23, 2020
|
Bought
2.74 K USD
|
Slifka Andrew P.
Executive Vice President
|
+ 200
|
13.72 USD |
|
4 years ago
Mar 19, 2020
|
Bought
29.6 K USD
|
McCool Robert J
Director
|
+ 3000
|
9.86 USD |
|
4 years ago
Mar 19, 2020
|
Bought
3.98 K USD
|
Slifka Eric
President and CEO
|
+ 370
|
10.75 USD |
|
4 years ago
Mar 18, 2020
|
Bought
33.2 K USD
|
Slifka Eric
President and CEO
|
+ 3300
|
10.07 USD |
|
6 years ago
Dec 11, 2018
|
Sell 45.4 K
USD
|
MCKOWN DAVID K
Director
|
- 2715
|
16.71 USD |
|
9 years ago
Dec 24, 2015
|
Sell 15.1 M
USD
|
Slifka Alfred A
10 percent owner
|
- 879373
|
17.2 USD |
|
9 years ago
Sep 14, 2015
|
Bought
239 K USD
|
Global GP LLC
|
+ 7901
|
30.25 USD |
|
9 years ago
Sep 11, 2015
|
Bought
361 K USD
|
Global GP LLC
|
+ 11788
|
30.65 USD |
|
9 years ago
Sep 10, 2015
|
Bought
302 K USD
|
Global GP LLC
|
+ 9877
|
30.57 USD |
|
9 years ago
Sep 09, 2015
|
Bought
318 K USD
|
Global GP LLC
|
+ 10000
|
31.83 USD |
|
9 years ago
Sep 04, 2015
|
Bought
109 K USD
|
Global GP LLC
|
+ 3400
|
32.01 USD |
|
9 years ago
Sep 02, 2015
|
Bought
31.1 K USD
|
Foster Daphne H.
CFO
|
+ 1000
|
31.1 USD |
|
9 years ago
Sep 02, 2015
|
Bought
31.2 K USD
|
Foster Daphne H.
CFO
|
+ 1000
|
31.25 USD |
|
9 years ago
Sep 03, 2015
|
Bought
52.7 K USD
|
Global GP LLC
|
+ 1646
|
31.99 USD |
|
9 years ago
Sep 02, 2015
|
Bought
66 K USD
|
Global GP LLC
|
+ 2101
|
31.41 USD |
|
9 years ago
Aug 13, 2015
|
Bought
120 K USD
|
WATCHMAKER KENNETH I
Director
|
+ 3800
|
31.6 USD |
|
9 years ago
Mar 23, 2015
|
Bought
906 K USD
|
Global GP LLC
|
+ 23800
|
38.07 USD |
|
9 years ago
Mar 20, 2015
|
Bought
789 K USD
|
Global GP LLC
|
+ 21000
|
37.57 USD |
|
9 years ago
Mar 19, 2015
|
Bought
462 K USD
|
Global GP LLC
|
+ 12600
|
36.66 USD |
|
9 years ago
Mar 18, 2015
|
Bought
283 K USD
|
Global GP LLC
|
+ 7925
|
35.7 USD |
|
12 years ago
May 31, 2012
|
Bought
30.2 K USD
|
WATCHMAKER KENNETH I
Director
|
+ 1400
|
21.5799 USD |
|
10 years ago
Dec 24, 2014
|
Bought
107 K USD
|
Global GP LLC
Director
|
+ 3100
|
34.44 USD |
|
10 years ago
Dec 23, 2014
|
Bought
337 K USD
|
Global GP LLC
Director
|
+ 9643
|
34.98 USD |
|
10 years ago
Dec 22, 2014
|
Bought
973 K USD
|
Global GP LLC
Director
|
+ 29000
|
33.55 USD |
|
10 years ago
Dec 19, 2014
|
Bought
1.37 M USD
|
Global GP LLC
Director
|
+ 40000
|
34.32 USD |
|
10 years ago
Dec 18, 2014
|
Bought
1.41 M USD
|
Global GP LLC
Director
|
+ 40000
|
35.35 USD |
|
10 years ago
Dec 19, 2014
|
Bought
1.37 M USD
|
Global GP LLC
Director
|
+ 40000
|
34.32 USD |
|
10 years ago
Dec 18, 2014
|
Bought
1.41 M USD
|
Global GP LLC
Director
|
+ 40000
|
35.35 USD |
|
10 years ago
Sep 08, 2014
|
Bought
52 K USD
|
Global GP LLC
Director
|
+ 1302
|
39.92 USD |
|
10 years ago
Aug 15, 2014
|
Bought
2.03 M USD
|
Global GP LLC
Director
|
+ 50007
|
40.61 USD |
|
10 years ago
Aug 13, 2014
|
Bought
259 K USD
|
Global GP LLC
Director
|
+ 6600
|
39.22 USD |
|
10 years ago
Aug 12, 2014
|
Bought
257 K USD
|
Global GP LLC
Director
|
+ 6600
|
38.91 USD |
|
10 years ago
Jun 05, 2014
|
Bought
229 K USD
|
Global GP LLC
Director
|
+ 5600
|
40.95 USD |
|
10 years ago
Jun 04, 2014
|
Bought
172 K USD
|
Global GP LLC
Director
|
+ 4200
|
40.84 USD |
|
10 years ago
Jun 03, 2014
|
Bought
228 K USD
|
Global GP LLC
Director
|
+ 5600
|
40.68 USD |
|
10 years ago
May 30, 2014
|
Bought
207 K USD
|
Global GP LLC
Director
|
+ 5100
|
40.68 USD |
|
10 years ago
May 28, 2014
|
Bought
206 K USD
|
Global GP LLC
Director
|
+ 5100
|
40.42 USD |
|
10 years ago
May 27, 2014
|
Bought
205 K USD
|
Global GP LLC
Director
|
+ 5100
|
40.21 USD |
|
10 years ago
May 23, 2014
|
Bought
183 K USD
|
Global GP LLC
Director
|
+ 4500
|
40.69 USD |
|
10 years ago
May 21, 2014
|
Bought
196 K USD
|
Global GP LLC
Director
|
+ 4800
|
40.83 USD |
|
10 years ago
May 20, 2014
|
Bought
196 K USD
|
Global GP LLC
Director
|
+ 4800
|
40.9 USD |
|
11 years ago
Dec 11, 2013
|
Bought
259 K USD
|
Global GP LLC
Director
|
+ 7500
|
34.51 USD |
|
11 years ago
Nov 15, 2013
|
Bought
49.9 K USD
|
WATCHMAKER KENNETH I
Director
|
+ 1450
|
34.44 USD |
|
11 years ago
Aug 22, 2013
|
Bought
179 K USD
|
Global GP LLC
Director
|
+ 5000
|
35.75 USD |
|
11 years ago
Aug 21, 2013
|
Bought
700 K USD
|
Global GP LLC
Director
|
+ 20000
|
34.99 USD |
|
11 years ago
Aug 20, 2013
|
Bought
694 K USD
|
Global GP LLC
Director
|
+ 20000
|
34.69 USD |
|
11 years ago
Aug 19, 2013
|
Bought
695 K USD
|
Global GP LLC
Director
|
+ 20000
|
34.73 USD |
|
11 years ago
Aug 16, 2013
|
Bought
574 K USD
|
Global GP LLC
Director
|
+ 16600
|
34.56 USD |
|
11 years ago
Aug 15, 2013
|
Bought
599 K USD
|
Global GP LLC
Director
|
+ 17400
|
34.43 USD |
|
11 years ago
Aug 14, 2013
|
Bought
599 K USD
|
Global GP LLC
Director
|
+ 17400
|
34.42 USD |
|
11 years ago
Aug 13, 2013
|
Bought
288 K USD
|
Global GP LLC
Director
|
+ 8941
|
32.17 USD |
|
12 years ago
Jun 25, 2012
|
Bought
96.2 K USD
|
Global GP LLC
Director
|
+ 4700
|
20.47 USD |
|
12 years ago
Jun 21, 2012
|
Bought
206 K USD
|
Global GP LLC
Director
|
+ 10000
|
20.59 USD |
|
12 years ago
Jun 15, 2012
|
Bought
8.44 K USD
|
Global GP LLC
Director
|
+ 400
|
21.1 USD |
|
12 years ago
Jun 14, 2012
|
Bought
214 K USD
|
Global GP LLC
Director
|
+ 10000
|
21.39 USD |
|
12 years ago
Jun 04, 2012
|
Bought
198 K USD
|
Global GP LLC
Director
|
+ 9800
|
20.21 USD |
|
12 years ago
Jun 01, 2012
|
Bought
233 K USD
|
Global GP LLC
Director
|
+ 11031
|
21.13 USD |
|
12 years ago
May 31, 2012
|
Bought
147 K USD
|
Global GP LLC
Director
|
+ 6900
|
21.37 USD |
|
12 years ago
May 30, 2012
|
Bought
58 K USD
|
Global GP LLC
Director
|
+ 2700
|
21.48 USD |
|
12 years ago
May 25, 2012
|
Bought
87.9 K USD
|
Global GP LLC
Director
|
+ 4000
|
21.98 USD |
|
12 years ago
May 23, 2012
|
Bought
65.4 K USD
|
Global GP LLC
Director
|
+ 3090
|
21.18 USD |
|
12 years ago
May 21, 2012
|
Bought
4.23 K USD
|
Global GP LLC
Director
|
+ 200
|
21.13 USD |
|
12 years ago
May 18, 2012
|
Bought
157 K USD
|
Global GP LLC
Director
|
+ 7462
|
21.08 USD |
|
12 years ago
May 17, 2012
|
Bought
160 K USD
|
Global GP LLC
Director
|
+ 7400
|
21.56 USD |
|
12 years ago
May 16, 2012
|
Bought
165 K USD
|
Global GP LLC
Director
|
+ 7500
|
21.97 USD |
|
12 years ago
May 15, 2012
|
Bought
217 K USD
|
Global GP LLC
Director
|
+ 10000
|
21.72 USD |
|
12 years ago
May 14, 2012
|
Bought
131 K USD
|
Global GP LLC
Director
|
+ 6100
|
21.45 USD |
|
13 years ago
Mar 01, 2012
|
Bought
0 USD
|
Slifka Richard
director, 10 percent owner:
|
+ 5850000
|
0 USD |
|
13 years ago
Mar 01, 2012
|
Bought
0 USD
|
Slifka Alfred A
director, 10 percent owner:
|
+ 5850000
|
0 USD |
|
13 years ago
Sep 09, 2011
|
Bought
133 K USD
|
Global GP LLC
Director
|
+ 6500
|
20.48 USD |
|
13 years ago
Sep 07, 2011
|
Bought
92 K USD
|
Global GP LLC
Director
|
+ 4600
|
19.99 USD |
|
13 years ago
Aug 22, 2011
|
Bought
92.2 K USD
|
Global GP LLC
Director
|
+ 5000
|
18.43 USD |
|
13 years ago
Aug 18, 2011
|
Bought
190 K USD
|
Global GP LLC
Director
|
+ 10000
|
19.04 USD |
|
13 years ago
May 17, 2011
|
Bought
54.8 K USD
|
Global GP LLC
Director
|
+ 2200
|
24.9 USD |
|
13 years ago
May 13, 2011
|
Bought
69.7 K USD
|
Global GP LLC
Director
|
+ 2800
|
24.9 USD |
|
13 years ago
May 12, 2011
|
Bought
25 K USD
|
Global GP LLC
Director
|
+ 1000
|
25 USD |
|
14 years ago
Nov 22, 2010
|
Bought
767 K USD
|
Global GP LLC
Director
|
+ 29400
|
26.08 USD |
|
14 years ago
Nov 18, 2010
|
Bought
83.6 K USD
|
Global GP LLC
Director
|
+ 3300
|
25.34 USD |
|
14 years ago
Nov 17, 2010
|
Bought
89.4 K USD
|
WATCHMAKER KENNETH I
Director
|
+ 3500
|
25.54 USD |
|
14 years ago
Nov 17, 2010
|
Bought
30.3 K USD
|
Global GP LLC
Director
|
+ 1200
|
25.22 USD |
|
15 years ago
Dec 10, 2009
|
Bought
30.2 K USD
|
Global GP LLC
Director
|
+ 1300
|
23.23 USD |
|
15 years ago
Dec 04, 2009
|
Bought
19 K USD
|
Global GP LLC
Director
|
+ 800
|
23.75 USD |
|
15 years ago
Dec 03, 2009
|
Bought
142 K USD
|
Global GP LLC
Director
|
+ 6000
|
23.72 USD |
|
15 years ago
Dec 02, 2009
|
Bought
56.8 K USD
|
Global GP LLC
Director
|
+ 2400
|
23.65 USD |
|
15 years ago
Dec 01, 2009
|
Bought
7.05 K USD
|
Global GP LLC
Director
|
+ 300
|
23.5 USD |
|
15 years ago
Nov 27, 2009
|
Bought
21.4 K USD
|
Global GP LLC
Director
|
+ 900
|
23.75 USD |
|
15 years ago
Nov 25, 2009
|
Bought
7.12 K USD
|
Global GP LLC
Director
|
+ 300
|
23.75 USD |
|
15 years ago
Nov 24, 2009
|
Bought
16.6 K USD
|
Global GP LLC
Director
|
+ 700
|
23.69 USD |
|
15 years ago
Nov 19, 2009
|
Bought
71.1 K USD
|
Global GP LLC
Director
|
+ 3000
|
23.71 USD |
|
15 years ago
Nov 16, 2009
|
Bought
57.5 K USD
|
Global GP LLC
Director
|
+ 2500
|
22.99 USD |
|
15 years ago
Nov 12, 2009
|
Bought
43.3 K USD
|
Global GP LLC
Director
|
+ 1900
|
22.77 USD |
|
15 years ago
Nov 11, 2009
|
Bought
18.4 K USD
|
Global GP LLC
Director
|
+ 800
|
23 USD |
|
15 years ago
Sep 10, 2009
|
Bought
185 K USD
|
Global GP LLC
Director
|
+ 7700
|
24.04 USD |
|
15 years ago
Sep 09, 2009
|
Bought
13.9 K USD
|
Global GP LLC
Director
|
+ 600
|
23.19 USD |
|
15 years ago
Sep 08, 2009
|
Bought
146 K USD
|
Global GP LLC
Director
|
+ 6400
|
22.89 USD |
|
15 years ago
Sep 04, 2009
|
Bought
158 K USD
|
Global GP LLC
Director
|
+ 6900
|
22.85 USD |
|
15 years ago
Sep 03, 2009
|
Bought
155 K USD
|
Global GP LLC
Director
|
+ 6900
|
22.53 USD |
|
15 years ago
Sep 01, 2009
|
Bought
26.4 K USD
|
Global GP LLC
Director
|
+ 1200
|
22 USD |
|
15 years ago
Aug 31, 2009
|
Bought
41.3 K USD
|
Global GP LLC
Director
|
+ 1900
|
21.76 USD |
|
15 years ago
Aug 27, 2009
|
Bought
106 K USD
|
Global GP LLC
Director
|
+ 4800
|
22.13 USD |
|
15 years ago
Aug 21, 2009
|
Bought
110 K USD
|
Global GP LLC
Director
|
+ 4900
|
22.42 USD |
|
15 years ago
Aug 20, 2009
|
Bought
98.9 K USD
|
Global GP LLC
Director
|
+ 4500
|
21.98 USD |
|
15 years ago
Aug 19, 2009
|
Bought
106 K USD
|
Global GP LLC
Director
|
+ 4900
|
21.63 USD |
|
15 years ago
Aug 18, 2009
|
Bought
86.6 K USD
|
Global GP LLC
Director
|
+ 4000
|
21.65 USD |
|
15 years ago
Aug 17, 2009
|
Bought
22.2 K USD
|
Global GP LLC
Director
|
+ 1056
|
21.01 USD |
|
15 years ago
Aug 12, 2009
|
Bought
54 K USD
|
Global GP LLC
Director
|
+ 2500
|
21.59 USD |
|
15 years ago
Aug 11, 2009
|
Bought
54 K USD
|
Global GP LLC
Director
|
+ 2535
|
21.3 USD |
|
15 years ago
Aug 14, 2009
|
Bought
85.3 K USD
|
Global GP LLC
Director
|
+ 3900
|
21.88 USD |
|
15 years ago
Aug 13, 2009
|
Bought
103 K USD
|
Global GP LLC
Director
|
+ 4700
|
21.98 USD |
|
15 years ago
Aug 12, 2009
|
Bought
54 K USD
|
Global GP LLC
Director
|
+ 2500
|
21.59 USD |
|
15 years ago
Aug 11, 2009
|
Bought
54 K USD
|
Global GP LLC
Director
|
+ 2535
|
21.3 USD |
|
15 years ago
Jul 10, 2009
|
Bought
52.3 K USD
|
Global GP LLC
Director
|
+ 2969
|
17.6 USD |
|
15 years ago
Jul 09, 2009
|
Bought
28.6 K USD
|
Global GP LLC
Director
|
+ 1612
|
17.73 USD |
|
15 years ago
Jul 08, 2009
|
Bought
178 K USD
|
Global GP LLC
Director
|
+ 10044
|
17.75 USD |
|
15 years ago
Jul 07, 2009
|
Bought
139 K USD
|
Global GP LLC
Director
|
+ 7698
|
18.04 USD |
|
15 years ago
Jul 06, 2009
|
Bought
62.7 K USD
|
Global GP LLC
Director
|
+ 3402
|
18.43 USD |
|
15 years ago
Jul 02, 2009
|
Bought
1.8 K USD
|
Global GP LLC
Director
|
+ 100
|
18 USD |
|
15 years ago
Jul 01, 2009
|
Bought
39.5 K USD
|
Global GP LLC
Director
|
+ 2200
|
17.97 USD |
|
15 years ago
Jun 30, 2009
|
Bought
74.6 K USD
|
Global GP LLC
Director
|
+ 4000
|
18.64 USD |
|
15 years ago
Jun 29, 2009
|
Bought
38 K USD
|
Global GP LLC
Director
|
+ 2000
|
18.98 USD |
|
15 years ago
Jun 24, 2009
|
Bought
190 K USD
|
Global GP LLC
Director
|
+ 10301
|
18.48 USD |
|
15 years ago
Jun 23, 2009
|
Bought
192 K USD
|
Global GP LLC
Director
|
+ 10345
|
18.53 USD |
|
15 years ago
Jun 22, 2009
|
Bought
154 K USD
|
Global GP LLC
Director
|
+ 8275
|
18.61 USD |
|
15 years ago
Jun 18, 2009
|
Bought
75.7 K USD
|
Global GP LLC
Director
|
+ 4144
|
18.26 USD |
|
15 years ago
Jun 18, 2009
|
Bought
59.5 K USD
|
Global GP LLC
Director
|
+ 3400
|
17.5 USD |
|
15 years ago
Jun 17, 2009
|
Bought
25.5 K USD
|
Global GP LLC
Director
|
+ 1400
|
18.19 USD |
|
15 years ago
Jun 17, 2009
|
Bought
159 K USD
|
Global GP LLC
Director
|
+ 9157
|
17.41 USD |
|
15 years ago
Jun 16, 2009
|
Bought
11.7 K USD
|
Global GP LLC
Director
|
+ 600
|
19.53 USD |
|
15 years ago
Jun 16, 2009
|
Bought
118 K USD
|
Global GP LLC
Director
|
+ 6294
|
18.81 USD |
|
15 years ago
Jun 11, 2009
|
Bought
44.6 K USD
|
Global GP LLC
Director
|
+ 2500
|
17.84 USD |
|
15 years ago
Jun 10, 2009
|
Bought
47 K USD
|
Global GP LLC
Director
|
+ 2611
|
18 USD |
|
15 years ago
Jun 03, 2009
|
Bought
86.6 K USD
|
Global GP LLC
Director
|
+ 4848
|
17.86 USD |
|
15 years ago
Jun 02, 2009
|
Bought
37.7 K USD
|
Global GP LLC
Director
|
+ 2100
|
17.94 USD |
|
15 years ago
Jun 02, 2009
|
Bought
87.1 K USD
|
Global GP LLC
Director
|
+ 5000
|
17.42 USD |
|
16 years ago
Nov 28, 2008
|
Bought
41.5 K USD
|
McCool Robert J
Director
|
+ 4000
|
10.37 USD |
|
17 years ago
Aug 16, 2007
|
Bought
5.35 K USD
|
Slifka Eric
President & CEO
|
+ 200
|
26.75 USD |
|
17 years ago
Aug 16, 2007
|
Bought
5.34 K USD
|
Slifka Eric
President & CEO
|
+ 200
|
26.72 USD |
|
17 years ago
Aug 16, 2007
|
Bought
2.67 K USD
|
Slifka Eric
President & CEO
|
+ 100
|
26.68 USD |
|
17 years ago
Aug 16, 2007
|
Bought
10.6 K USD
|
Slifka Eric
President & CEO
|
+ 400
|
26.44 USD |
|
17 years ago
Aug 16, 2007
|
Bought
5.29 K USD
|
Slifka Eric
President & CEO
|
+ 200
|
26.43 USD |
|
17 years ago
Aug 16, 2007
|
Bought
2.64 K USD
|
Slifka Eric
President & CEO
|
+ 100
|
26.36 USD |
|
17 years ago
Aug 16, 2007
|
Bought
7.9 K USD
|
Slifka Eric
President & CEO
|
+ 300
|
26.35 USD |
|
17 years ago
Aug 16, 2007
|
Bought
2.63 K USD
|
Slifka Eric
President & CEO
|
+ 100
|
26.26 USD |
|
19 years ago
Oct 04, 2005
|
Bought
561 K USD
|
Slifka Eric
President and CEO
|
+ 25500
|
22 USD |
|
19 years ago
Oct 04, 2005
|
Bought
273 K USD
|
Faneuil Edward J
Executive VP and GC
|
+ 12400
|
22 USD |
|
19 years ago
Oct 04, 2005
|
Bought
110 K USD
|
Rudinsky Charles A
Sr. VP & Chief Accounting Off.
|
+ 5000
|
22 USD |
|
19 years ago
Oct 04, 2005
|
Bought
48.1 K USD
|
McManmon Thomas A Jr
Executive VP and CFO
|
+ 2000
|
24.05 USD |
|
19 years ago
Oct 04, 2005
|
Bought
638 K USD
|
McManmon Thomas A Jr
Executive VP and CFO
|
+ 29000
|
22 USD |
7. News
3 Solid Options Amid Refining & Marketing MLP Industry Tumult
Following a careful analysis of the Zacks Oil and Gas - Refining & Marketing MLP industry, we advise focusing on companies like TRGP, GLP and CAPL.
zacks.com
- 1 week ago
Shattuck Labs Announces Positive Data from the Preclinical GLP Toxicology Study of SL-325 at the 20th Congress of European Crohn's and Colitis Organization (ECCO) in Inflammatory Bowel Diseases 2025
– SL-325 is a high-affinity DR3 blocking antibody being developed for the treatment of inflammatory bowel disease (IBD); No evidence of toxicity or residual agonism observed in non-human primate toxicology study – – SL-325 receptor occupancy (RO) and pharmacokinetic (PK) profile observed suggestive of extended dosing intervals; IND filing expected in the third quarter of 2025 – AUSTIN, TX & DURHAM, NC, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for the treatment of patients with inflammatory and immune-related diseases, today announced positive preclinical data from an IND-enabling GLP toxicology study of SL-325 in non-human primates (NHP). These data were featured in a digital oral presentation on February 20, 2025, during the 20th Congress of ECCO in Inflammatory Bowel Diseases 2025 in Berlin, Germany.
globenewswire.com
- 1 week ago
Novo Nordisk Prices In Too Few New Patients For GLP-1 Currently
Novo Nordisk only prices in management's latest year guidance and underestimates the full market potential. Adding 5m GLP-1 patients at slightly lower prices or 21m at LLY price levels both lead to 20%+ upside in the stock. Both diabetes and obesity are blue ocean markets, composed of low GLP-1 usage.
seekingalpha.com
- 1 week ago
Ascletis Announces Positive Interim Results from First Two Cohorts of U.S. Phase Ib Multiple Ascending Dose Study of Small Molecule Oral GLP-1R Agonist ASC30
- ASC30 oral once-daily tablet demonstrated a 6.3% mean body weight reduction from baseline after 28-day treatment in multiple ascending dose (MAD) c ohort 2 (weekly titrations of 2 mg, 10 mg, 20 mg , and 40 mg). - ASC30 oral once-daily tablet also demonstrated a 4.3% mean body weight reduction from baseline after 28-day treatment in MAD cohort 1 (weekly titrations of 2 mg, 5 mg, 10 mg , and 20 mg).
prnewswire.com
- 1 week ago
Global Partners LP to Host Fourth-Quarter and Full-Year 2024 Financial Results Conference Call on February 28, 2025
WALTHAM, Mass.--(BUSINESS WIRE)--Global Partners LP (NYSE: GLP) (the “Partnership”) today announced that it will release its fourth-quarter and full-year 2024 financial results before the market opens on Friday, February 28, 2025. At 10:00 a.m. ET, the Partnership will conduct a conference call for investors and analysts hosted by Eric Slifka, President and Chief Executive Officer, Gregory B. Hanson, Chief Financial Officer, and Mark Romaine, Chief Operating Officer. The call can be accessed by.
businesswire.com
- 2 weeks ago
GLP-1 Drugs Drive Growth for Eli Lilly. Is the Stock a Buy?
After pre-announcing that its full-year revenue would come in below its original guidance, Eli Lilly (LLY 0.92%) announced its full results and reiterated its earlier 2025 forecast. The company has been a big beneficiary of GLP-1 drugs that have seen soaring demand as they have been shown to greatly help with multiple health issues, including weight control.
fool.com
- 2 weeks ago
GLP-1 Alternatives: 2 Stocks Benefiting From Weight Loss Trends
The supply shortage and high costs of GLP-1 weight loss drugs have created an opportunity for compounded GLP-1 treatments to hit the market and disrupt the medical sector. These treatments are permitted when drugs are listed on the FDA's list of drug shortages.
marketbeat.com
- 2 weeks ago
Lexaria Biodistribution Study For DehydraTECH GLP-1 is Underway
World's First-Ever Study Tracking Biodistribution of DehydraTECH GLP-1 Molecules KELOWNA, BC / ACCESS Newswire / February 6, 2025 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces that dosing has begun in its fluorescently tagged DehydraTECH-semaglutide ("FTS") rodent biodistribution study (the "Study"). Distribution of a drug once it enters the body can provide vital clues as to the understanding of that drug's ability to bind with targeted receptor cells, avoid concentration at physical sites that might be prone to fostering adverse side effects, and increase the drug's ultimate efficacy.
accessnewswire.com
- 3 weeks ago
Lexaria Biodistribution Study For DehydraTECH GLP-1 is Underway
World's First-Ever Study Tracking Biodistribution of DehydraTECH GLP-1 Molecules Kelowna, British Columbia – February 6, 2024 – TheNewswire - Lexaria Bioscience Corp. (Nasdaq: LEXX, LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, announces that dosing has begun in its fluorescently tagged DehydraTECH-semaglutide (“ FTS ”) rodent biodistribution study (the “ Study ”).
thenewswire.com
- 3 weeks ago
Lexaria Updates its Ongoing Human Study GLP-1-H24-4
Registered Phase-1b 12-week study investigating safety, diabetes control, and weight loss KELOWNA, BC / ACCESS Newswire / February 5, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to provide progress updates on its Phase 1b, 12-week chronic study GLP-1-H24-4 (the "Study") underway in Australia. Lexaria has completed its submission to the human research ethics committee ("HREC") for its planned addition of Study Arm 5 to evaluate performance of its DehydraTECH-tirzepatide formulation, pursuant to the positive findings it previously achieved and released for Human Pilot Study #3 (GLP-1-H24-3).
accessnewswire.com
- 3 weeks ago
Viking Therapeutics: Why The Oral VK2735 Phase 2 Readout Could Send The Stock Soaring
Oral VK2735 is strategically positioned to become a best-in-class oral GLP-1 therapy, with the Phase 2 trial data readout in H2 2025 serving as a critical catalyst. Phase 1 data for VK2735 represents the best efficacy and safety profile ever reported for an oral GLP-1 drug. The oral obesity market is projected to be the fastest-growing segment within the broader weight-loss market, driven by the superior convenience of oral formulations compared to injectable treatments.
seekingalpha.com
- 3 weeks ago
Healthy Returns: Why people quit weight loss, diabetes drugs within one year
A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to focus on GLP-1 products.
cnbc.com
- 3 weeks ago
8. Profile
Summary
Global Partners LP GLP
COUNTRY
US
INDUSTRY
Oil & Gas Midstream
MARKET CAP
$ 1.97 B
Dividend Yield
1.89%
Description
Global Partners LP engages in the purchasing, selling, gathering, blending, storing, and logistics of transporting gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude oil, and propane to wholesalers, retailers, and commercial customers in the New England states, Mid-Atlantic region, and New York. The company is also involved in the transportation of petroleum products and renewable fuels through rail from the mid-continent region of the United States and Canada. Its Wholesale segment sells home heating oil, branded and unbranded gasoline and gasoline blendstocks, diesel, kerosene, residual oil, and propane to home heating oil retailers and wholesale distributors. It also aggregates crude oil through truck or pipeline in the mid-continent region of the United States and Canada, as well as transports it through rail and ships it through barge to refiners. The company's Gasoline Distribution and Station Operations segment sells branded and unbranded gasoline to gasoline station operators and sub-jobbers; operates gasoline stations and convenience stores; and provides car wash, lottery, and ATM services, as well as leases gasoline stations. Its Commercial segment sells and delivers unbranded gasoline, home heating oil, diesel, kerosene, residual oil, and bunker fuel to customers in the public sector, as well as to commercial and industrial end-users; and sells custom blended fuels. As of December 31, 2021, the company had a portfolio of 1,595 owned, leased, and supplied gasoline stations, which included 295 directly operated convenience stores; and owned, leased, or maintained storage facilities at 26 bulk terminals with a collective storage capacity of 11.9 million barrels. Global GP LLC serves as the general partner of the company. The company was incorporated in 2005 and is based in Waltham, Massachusetts.
Contact
800 South Street, Waltham, MA, 02454-9161
https://www.globalp.com
IPO
Date
Sept. 29, 2005
Employees
3485
Officers
Mr. Matthew Spencer
Chief Accounting Officer of Global GP LLC
Philip Segaloff
Senior Associate General Counsel
Lorraine Spadaro
Chief Information Officer
Catie Kerns
Senior Vice President of Corporate Affairs and Sustainability & VP of Communications
Mr. Scott Solomon
Vice President of Investor Relations
Mr. Eric S. Slifka
President, Chief Executive Officer & Vice Chairman of Global GP LLC
Mr. Sean T. Geary
Chief Legal Officer & Secretary
Mr. Gregory B. Hanson
Chief Financial Officer of Global GP LLC
Ms. Maura McDonough
Chief People Officer
Mr. Mark A. Romaine
Chief Operating Officer of Global GP LLC